Work

Supplementary Information from Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma

Year: 2023
Type: supplementary-materials
Abstract: This document contains Supplementary information, including materials and methods as well as Figure Legends for the Supplementary Figures.
Language: English
Subfield: Neurology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361921995
Cites:
Cited by:
Related to: 6